Literature DB >> 17694350

Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening.

S Vermeer1, H P H Kremer, Q H Leijten, H Scheffer, G Matthijs, R A Wevers, N A V M Knoers, E Morava, D J Lefeber.   

Abstract

Cerebellar ataxia can have many genetic causes among which are the congenital disorders of glycosylation type I (CDG-I). In this group of disorders, a multisystem phenotype is generally observed including the involvement of many organs, the endocrine, hematologic and central nervous systems. A few cases of CDG-Ia have been reported with a milder presentation, namely cerebellar hypoplasia as an isolated abnormality. To identify patients with a glycosylation disorder, isofocusing of plasma transferrin is routinely performed. Here, we describe two CDG-Ia patients,who presented with mainly ataxia and cerebellar hypoplasia and with a normal or only slightly abnormal transferrin isofocusing result. Surprisingly, the activity of the corresponding enzyme phosphomannomutase was clearly deficient in both leucocytes and fibroblasts. Therefore, in patients presenting with apparently recessive inherited ataxia caused by cerebellar hypoplasia and an unknown genetic aetiology after proper diagnostic work-up, we recommend the measurement of phosphomannomutase activity when transferrin isofocusing is normal or inconclusive.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694350     DOI: 10.1007/s00415-007-0546-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  Carbohydrate-deficient glycoprotein syndrome: beyond the screen.

Authors:  J M Fletcher; G Matthijs; J Jaeken; E Van Schaftingen; P V Nelson
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

2.  Congenital disorder of glycosylation type Ia: benign clinical course in a new genetic variant.

Authors:  Irina Mader; Marion Döbler-Neumann; Wilhelm Küker; Helena Stibler; Ingeborg Krägeloh-Mann
Journal:  Childs Nerv Syst       Date:  2001-09-22       Impact factor: 1.475

3.  Stabilization of hypoglycosylation in a patient with congenital disorder of glycosylation type Ia.

Authors:  S H Hahn; S J Minnich; J F O'Brien
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Congenital disorder of glycosylation type Ia presenting with hydrops fetalis.

Authors:  J M van de Kamp; D J Lefeber; G J G Ruijter; S J Steggerda; N S den Hollander; S M Willems; G Matthijs; B J H M Poorthuis; R A Wevers
Journal:  J Med Genet       Date:  2006-12-08       Impact factor: 6.318

5.  Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.

Authors:  A Erlandson; C Bjursell; H Stibler; B Kristiansson; J Wahlström; T Martinsson
Journal:  Hum Genet       Date:  2001-05       Impact factor: 4.132

6.  Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).

Authors:  G Matthijs; E Schollen; E Pardon; M Veiga-Da-Cunha; J Jaeken; J J Cassiman; E Van Schaftingen
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

7.  Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).

Authors:  G Matthijs; E Schollen; C Bjursell; A Erlandson; H Freeze; F Imtiaz; S Kjaergaard; T Martinsson; M Schwartz; N Seta; S Vuillaumier-Barrot; V Westphal; B Winchester
Journal:  Hum Mutat       Date:  2000-11       Impact factor: 4.878

8.  Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A.

Authors:  G Matthijs; E Schollen; E Van Schaftingen; J J Cassiman; J Jaeken
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

9.  Neurological presentation of a congenital disorder of glycosylation CDG-Ia: implications for diagnosis and genetic counseling.

Authors:  V Drouin-Garraud; M Belgrand; S Grünewald; N Seta; J N Dacher; A Hénocq; G Matthijs; V Cormier-Daire; T Frébourg; P Saugier-Veber
Journal:  Am J Med Genet       Date:  2001-06-01

10.  [CDG (congenital disorders of glycosylation). Differential hereditary ataxia in adulthood diagnosis].

Authors:  S Bubel; V Peters; C Klein; R Hackler; J R Schaefer; J Hagenah; G F Hoffmann; P Vieregge
Journal:  Nervenarzt       Date:  2002-08       Impact factor: 1.214

View more
  18 in total

1.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

Review 2.  Recognizable phenotypes in CDG.

Authors:  Carlos R Ferreira; Ruqaia Altassan; Dorinda Marques-Da-Silva; Rita Francisco; Jaak Jaeken; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2018-04-13       Impact factor: 4.982

3.  Mild clinical and biochemical phenotype in two patients with PMM2-CDG (congenital disorder of glycosylation Ia).

Authors:  M Casado; M M O'Callaghan; R Montero; C Pérez-Cerda; B Pérez; P Briones; E Quintana; J Muchart; A Aracil; M Pineda; R Artuch
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

4.  Normal glycosylation screening does not rule out SRD5A3-CDG.

Authors:  Miski Mohamed; Vincent Cantagrel; Lihadh Al-Gazali; Ron A Wevers; Dirk J Lefeber; Eva Morava
Journal:  Eur J Hum Genet       Date:  2011-07-13       Impact factor: 4.246

5.  DPAGT1 myasthenia and myopathy: genetic, phenotypic, and expression studies.

Authors:  Duygu Selcen; Xin-Ming Shen; Joan Brengman; Ying Li; Anthony A Stans; Eric Wieben; Andrew G Engel
Journal:  Neurology       Date:  2014-04-23       Impact factor: 9.910

6.  Three families with mild PMM2-CDG and normal cognitive development.

Authors:  Mari-Anne Vals; Eva Morava; Kai Teeäär; Riina Zordania; Sander Pajusalu; Dirk J Lefeber; Katrin Õunap
Journal:  Am J Med Genet A       Date:  2017-04-19       Impact factor: 2.802

7.  Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2.

Authors:  Oscar Rubio Cabezas; Sarah E Flanagan; Horia Stanescu; Elena García-Martínez; Richard Caswell; Hana Lango-Allen; Montserrat Antón-Gamero; Jesús Argente; Anna-Marie Bussell; Andre Brandli; Chris Cheshire; Elizabeth Crowne; Simona Dumitriu; Robert Drynda; Julian P Hamilton-Shield; Wesley Hayes; Alexis Hofherr; Daniela Iancu; Naomi Issler; Craig Jefferies; Peter Jones; Matthew Johnson; Anne Kesselheim; Enriko Klootwijk; Michael Koettgen; Wendy Lewis; José María Martos; Monika Mozere; Jill Norman; Vaksha Patel; Andrew Parrish; Celia Pérez-Cerdá; Jesús Pozo; Sofia A Rahman; Neil Sebire; Mehmet Tekman; Peter D Turnpenny; William Van't Hoff; Daan H H M Viering; Michael N Weedon; Patricia Wilson; Lisa Guay-Woodford; Robert Kleta; Khalid Hussain; Sian Ellard; Detlef Bockenhauer
Journal:  J Am Soc Nephrol       Date:  2017-04-03       Impact factor: 10.121

8.  SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder.

Authors:  Vincent Cantagrel; Dirk J Lefeber; Bobby G Ng; Ziqiang Guan; Jennifer L Silhavy; Stephanie L Bielas; Ludwig Lehle; Hans Hombauer; Maciej Adamowicz; Ewa Swiezewska; Arjan P De Brouwer; Peter Blümel; Jolanta Sykut-Cegielska; Scott Houliston; Dominika Swistun; Bassam R Ali; William B Dobyns; Dusica Babovic-Vuksanovic; Hans van Bokhoven; Ron A Wevers; Christian R H Raetz; Hudson H Freeze; Eva Morava; Lihadh Al-Gazali; Joseph G Gleeson
Journal:  Cell       Date:  2010-07-15       Impact factor: 41.582

9.  A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype.

Authors:  Zafar Iqbal; Mohsin Shahzad; Lisenka E L M Vissers; Monique van Scherpenzeel; Christian Gilissen; Attia Razzaq; Muhammad Yasir Zahoor; Shaheen N Khan; Tjitske Kleefstra; Joris A Veltman; Arjan P M de Brouwer; Dirk J Lefeber; Hans van Bokhoven; Sheikh Riazuddin
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

Review 10.  Congenital disorders of glycosylation: new defects and still counting.

Authors:  Kyle Scott; Therese Gadomski; Tamas Kozicz; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2014-05-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.